title: Mutational analysis of the antagonist-binding site of the histamine H(1) receptor.
abstract: We combined in a previously derived three-dimensional model of the histamine H(1) receptor (Ter Laak, A. M., Timmerman, H., Leurs, H., Nederkoorn, P. H. J., Smit, M. J., and Donne-Op den Kelder, G. M. (1995) J. Comp. Aid. Mol. Design. 9, 319-330) a pharmacophore for the H(1) antagonist binding site (Ter Laak, A. M., Venhorst, J., Timmerman, H., and Donné-Op de Kelder, G. M. (1994) J. Med. Chem. 38, 3351-3360) with the known interacting amino acid residue Asp(116) (in transmembrane domain III) of the H(1) receptor and verified the predicted receptor-ligand interactions by site-directed mutagenesis. This resulted in the identification of the aromatic amino acids Trp(167), Phe(433), and Phe(436) in transmembrane domains IV and VI of the H(1) receptor as probable interaction points for the trans-aromatic ring of the H(1) antagonists. Subsequently, a specific interaction of carboxylate moieties of two therapeutically important, zwitterionic H(1) antagonists with Lys(200) in transmembrane domain V was predicted. A Lys(200) --> Ala mutation results in a 50- (acrivastine) to 8-fold (d-cetirizine) loss of affinity of these zwitterionic antagonists. In contrast, the affinities of structural analogs of acrivastine and cetirizine lacking the carboxylate group, triprolidine and meclozine, respectively, are unaffected by the Lys(200) --> Ala mutation. These data strongly suggest that Lys(200), unique for the H(1) receptor, acts as a specific anchor point for these "second generation" H(1) antagonists.
authors.affiliation: Leiden/Amsterdam Center for Drug Research, Department of Pharmacochemistry, Division of Medicinal Chemistry, Faculty of Chemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, the Netherlands.
authors.forename: K
authors.initials: K
authors.lastname: Wieland
authors.forename: A M
authors.initials: AM
authors.lastname: Laak
authors.forename: M J
authors.initials: MJ
authors.lastname: Smit
authors.forename: R
authors.initials: R
authors.lastname: Kühne
authors.forename: H
authors.initials: H
authors.lastname: Timmerman
authors.forename: R
authors.initials: R
authors.lastname: Leurs
mesh_terms: D000818:Animals; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D017332:Cetirizine / Q000494:pharmacology; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000378:metabolism*; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D008024:Ligands; D008239:Lysine / Q000378:metabolism; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D011969:Receptors, Histamine H1 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D014311:Triprolidine / Q000031:analogs & derivatives / Q000378:metabolism
chemical_list: D006634:Histamine H1 Antagonists; D007295:Inositol Phosphates; D008024:Ligands; D011969:Receptors, Histamine H1; D014311:Triprolidine; D006632:Histamine; C043648:acrivastine; D008239:Lysine; D017332:Cetirizine